title: Biomarkers of inflammatory bowel disease.
abstract: Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease.
authors: Department of Oncology, Second Affiliated Hospital of Nanchang University, Minde Road 1, Nanchang, Jiangxi 330006, China.
authors: Yi
authors: Y
authors: Fengming
authors: Department of Oncology, Second Affiliated Hospital of Nanchang University, Minde Road 1, Nanchang, Jiangxi 330006, China.
authors: Wu
authors: W
authors: Jianbing
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D005243:Feces; D020022:Genetic Predisposition to Disease; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000235:genetics / Q000276:immunology / Q000378:metabolism*
chemical_list: D015415:Biomarkers